[Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].
Identifieur interne : 000014 ( PubMed/Checkpoint ); précédent : 000013; suivant : 000015[Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].
Auteurs :Source :
- Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases [ 1001-0939 ] ; 2020.
Abstract
Severe acute respiratory infection (SARI) diseases (such as SARS, MERS, pH1N1) can rapidly progress to acute respiratory failure with high lethality. The outbreak of a novel coronavirus infection can lead to 15% ~ 30% patients developing into acute respiratory distress syndrome (ARDS). Respiratory support is the most important therapy for SARI patients with respiratory failure. However, respiratory support is a high skilled technology, which means inappropriate application may bring related complications and cross infection of SARI pathogens among medical staff and non-medical personnel in hospital. Therefore, it is meaningful to established a standardized indication of respiratory support and to prevent related nosocomial transmission in SARI patients.
DOI: 10.3760/cma.j.issn.1001-0939.2020.0015
PubMed: 32061199
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:32061199Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].</title></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32061199</idno><idno type="pmid">32061199</idno><idno type="doi">10.3760/cma.j.issn.1001-0939.2020.0015</idno><idno type="wicri:Area/PubMed/Corpus">000231</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000231</idno><idno type="wicri:Area/PubMed/Curation">000231</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000231</idno><idno type="wicri:Area/PubMed/Checkpoint">000014</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000014</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].</title></analytic><series><title level="j">Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases</title><idno type="ISSN">1001-0939</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Severe acute respiratory infection (SARI) diseases (such as SARS, MERS, pH1N1) can rapidly progress to acute respiratory failure with high lethality. The outbreak of a novel coronavirus infection can lead to 15% ~ 30% patients developing into acute respiratory distress syndrome (ARDS). Respiratory support is the most important therapy for SARI patients with respiratory failure. However, respiratory support is a high skilled technology, which means inappropriate application may bring related complications and cross infection of SARI pathogens among medical staff and non-medical personnel in hospital. Therefore, it is meaningful to established a standardized indication of respiratory support and to prevent related nosocomial transmission in SARI patients.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32061199</PMID><DateRevised><Year>2020</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1001-0939</ISSN><JournalIssue CitedMedium="Print"><Volume>43</Volume><Issue>0</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases</Title><ISOAbbreviation>Zhonghua Jie He He Hu Xi Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].</ArticleTitle><Pagination><MedlinePgn>E015</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.1001-0939.2020.0015</ELocationID><Abstract><AbstractText>Severe acute respiratory infection (SARI) diseases (such as SARS, MERS, pH1N1) can rapidly progress to acute respiratory failure with high lethality. The outbreak of a novel coronavirus infection can lead to 15% ~ 30% patients developing into acute respiratory distress syndrome (ARDS). Respiratory support is the most important therapy for SARI patients with respiratory failure. However, respiratory support is a high skilled technology, which means inappropriate application may bring related complications and cross infection of SARI pathogens among medical staff and non-medical personnel in hospital. Therefore, it is meaningful to established a standardized indication of respiratory support and to prevent related nosocomial transmission in SARI patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><CollectiveName>Critical care committee of Chinese Association of Chest Physician</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Respiratory and critical care group of Chinese Thoracic Society</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Respiratory care group of Chinese Thoracic Society</CollectiveName></Author></AuthorList><Language>chi</Language><GrantList CompleteYN="Y"><Grant><GrantID>2016YFC1304300, 2018ZX09201013</GrantID><Agency>Supported by the National Key Research and Development Program of China</Agency><Country></Country></Grant><Grant><GrantID>2018- I2M-1-003</GrantID><Agency>CAMS Innovation Fund for Medical Sciences</Agency><Country></Country></Grant><Grant><GrantID>2019TX320006</GrantID><Agency>Non-profit Central Research Institute Fund of CAMS</Agency><Country></Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Jie He He Hu Xi Za Zhi</MedlineTA><NlmUniqueID>8712226</NlmUniqueID><ISSNLinking>1001-0939</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="chi"><AbstractText>严重急性呼吸道感染（SARI）疾病[如严重急性呼吸综合征（SARS）、中东呼吸综合征（MERS）、新型甲型H1N1流感病毒性肺炎（pH1N1）等]的部分患者可快速进展为急性呼吸衰竭，19%～32% SARS患者需要住ICU接受呼吸支持治疗。2019年12月，在武汉市爆发了一种新型冠状病毒（2019-nCoV）肺炎（NCP），约15%～30%患者会在短时间内进展为急性呼吸窘迫综合征（ARDS），且具有较强的传染性。呼吸支持技术是SARI患者最重要的生命支持手段，而呼吸支持相关设备与技术不恰当应用是导致院内医务人员和非医务人员感染SARI病原菌的重要原因，因此，加强呼吸支持技术的规范化应用以及预防相关的院内交叉感染是SARI患者呼吸管理的关键。.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">High Flow Nasal Cannula</Keyword><Keyword MajorTopicYN="N">Noninvasive positive pressure ventilation</Keyword><Keyword MajorTopicYN="N">Novel Coronavirus Pneumonia</Keyword><Keyword MajorTopicYN="N">Respiratory support</Keyword><Keyword MajorTopicYN="N">Severe Acute Respiratory Infections</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32061199</ArticleId><ArticleId IdType="doi">10.3760/cma.j.issn.1001-0939.2020.0015</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000014 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000014 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:32061199
|texte= [Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:32061199" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |